Is Buying CBIZ, Inc. (CBZ) Here a Winning Strategy?

February 15, 2018 - By Adrian Mccoy

Investors sentiment is 1.82 in Q3 2017. Its the same as in 2017Q2. It is flat, as 8 investors sold CBIZ, Inc. shares while 31 reduced holdings. only 17 funds opened positions while 54 raised stakes. 46.06 million shares or 0.80% less from 46.43 million shares in 2017Q2 were reported.
Schwab Charles Mgmt invested in 0.01% or 372,021 shares. Royal Bank Of Canada holds 0% of its portfolio in CBIZ, Inc. (NYSE:CBZ) for 51,083 shares. Ubs Asset Mngmt Americas holds 0% of its portfolio in CBIZ, Inc. (NYSE:CBZ) for 25,695 shares. Thrivent For Lutherans reported 242,741 shares. Tudor Investment Et Al stated it has 16,923 shares. 26,105 were accumulated by Sawgrass Asset Management Limited Liability. Suntrust Banks accumulated 20,580 shares. Clarivest Asset Management Ltd Limited Liability Company owns 609,568 shares or 0.22% of their US portfolio. Fmr Ltd Com holds 4.56 million shares or 0.01% of its portfolio. Connor Clark Lunn Inv Mngmt Ltd holds 46,325 shares or 0% of its portfolio. Bessemer Gp Incorporated holds 0.01% of its portfolio in CBIZ, Inc. (NYSE:CBZ) for 96,758 shares. Shell Asset Management holds 0.03% or 241,360 shares. Parametric Portfolio Ltd Liability invested in 0% or 147,238 shares. State Teachers Retirement System owns 4,500 shares. 275,055 are held by Boston Prtnrs.

Since August 31, 2017, it had 0 insider buys, and 6 insider sales for $2.20 million activity. 25,000 shares valued at $376,515 were sold by GROVE WARE H on Thursday, August 31. The insider Kouzelos Michael P sold $523,250. SPURIO CHRIS sold $246,724 worth of stock.

The stock of CBIZ, Inc. (NYSE:CBZ) is a huge mover today! The stock increased 10.92% or $1.775 during the last trading session, reaching $18.025. About 156,346 shares traded. CBIZ, Inc. (NYSE:CBZ) has risen 47.49% since February 15, 2017 and is uptrending. It has outperformed by 30.79% the S&P500.
The move comes after 5 months positive chart setup for the $975.24M company. It was reported on Feb, 15 by Barchart.com. We have $19.47 PT which if reached, will make NYSE:CBZ worth $78.02M more.

CBIZ, Inc. (NYSE:CBZ) Ratings Coverage

Among 2 analysts covering CBIZ (NYSE:CBZ), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. CBIZ had 6 analyst reports since October 7, 2015 according to SRatingsIntel. The firm earned “Underweight” rating on Thursday, October 29 by First Analysis. Sidoti initiated the shares of CBZ in report on Tuesday, July 19 with “Buy” rating. First Analysis upgraded the stock to “Equal-Weight” rating in Tuesday, March 15 report. The firm has “Equal-Weight” rating by First Analysis given on Wednesday, October 7. The company was upgraded on Thursday, January 21 by Sidoti. The company was downgraded on Tuesday, October 13 by Sidoti.

More recent CBIZ, Inc. (NYSE:CBZ) news were published by: Streetinsider.com which released: “CBIZ, Inc. (CBZ) Acquires Laurus Transaction Advisors” on February 02, 2018. Also Streetinsider.com published the news titled: “CBIZ, Inc. (CBZ) Tops Q4 EPS by 3c, Beats on Revenues” on February 15, 2018. Twst.com‘s news article titled: “CBIZ Inc.: CBIZ To Announce Fourth-Quarter And Full-Year 2017 Results On …” with publication date: January 31, 2018 was also an interesting one.

CBIZ, Inc., through its subsidiaries, provides professional business services, products, and solutions in the United States and Canada. The company has market cap of $975.24 million. It offers its services through three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. It has a 22.17 P/E ratio. The Financial Services practice group provides accounting and tax, government health care consulting, financial advisory, valuation, litigation support, risk and advisory, real estate consulting, and internal audit outsourcing services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: